Endonovo Therapeutics, Inc.
ENDV- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001528172
No open-market purchases or sales by Endonovo Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Endonovo Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 60 | +60 |
| Value | $0 | $0 | $0 |
New holders (1)
Institutions that held Endonovo Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Family CFO Inc | 60 | $0 | 0.00% |
Sold out (0)
Institutions that held Endonovo Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
None.